This Director role sits at the heart of Integrated Bioanalysis, driving end-to-end bioanalytical strategies that shape the future of our Oncology portfolio. The position leads the design and implementation of robust approaches for PK, immunogenicity and biomarker endpoints, ensuring assays are developed, validated and applied in line with their context of use. Working closely with internal laboratories and external CRO partners, the role provides scientific oversight across multiple modalities and stages of development. Acting as IBA project lead on selected programs, this Director partners with cross-functional teams to align on strategy, manage expectations and deliver high-quality data that informs key decisions. The role offers the chance to influence a diverse pipeline, contribute to departmental strategy and help advance life-changing medicines for patients with cancer.

Accountabilities

Based at one of our US research hubs in Gaithersburg, MD or Boston, MA,...